Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Lam Research (NASDAQ:LRCX) Stock Price

Lam Research (NASDAQ:LRCX) had its target price lifted by Deutsche Bank Aktiengesellschaft from $160.00 to $195.00 in a research report issued on Friday,MarketScreener reports. The brokerage currently has a “buy” rating on the semiconductor company’s stock. Deutsche Bank Aktiengesellschaft’s price objective would suggest a potential upside of 17.47% from the stock’s current price.

Other equities research analysts have also issued research reports about the stock. Sanford C. Bernstein increased their price objective on shares of Lam Research from $170.00 to $175.00 and gave the stock an “outperform” rating in a report on Friday, November 21st. Dbs Bank upped their price target on Lam Research from $119.40 to $184.20 in a research note on Monday, October 27th. Stifel Nicolaus set a $160.00 price objective on Lam Research and gave the stock a “buy” rating in a research report on Thursday, October 23rd. The Goldman Sachs Group upped their target price on shares of Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, October 8th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $210.00 price target on shares of Lam Research in a research note on Tuesday. Twenty-six investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $160.37.

Lam Research Trading Up 0.8%

Shares of NASDAQ:LRCX opened at $166.00 on Friday. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $208.50 billion, a PE ratio of 36.56, a P/E/G ratio of 1.59 and a beta of 1.77. Lam Research has a 1 year low of $56.32 and a 1 year high of $169.69. The firm has a fifty day moving average price of $154.01 and a 200 day moving average price of $122.18.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm’s revenue was up 27.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts expect that Lam Research will post 3.71 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Douglas R. Bettinger sold 40,080 shares of the company’s stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Ava Harter sold 9,010 shares of the firm’s stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the transaction, the insider directly owned 56,786 shares of the company’s stock, valued at $8,942,091.42. This represents a 13.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 102,608 shares of company stock valued at $14,916,496 in the last quarter. 0.31% of the stock is owned by company insiders.

Institutional Investors Weigh In On Lam Research

Several hedge funds have recently bought and sold shares of the company. IMG Wealth Management Inc. bought a new stake in Lam Research in the second quarter valued at approximately $26,000. Stance Capital LLC bought a new position in shares of Lam Research during the third quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research in the second quarter valued at approximately $27,000. Triumph Capital Management bought a new stake in shares of Lam Research in the third quarter valued at approximately $27,000. Finally, Strategic Wealth Investment Group LLC bought a new position in Lam Research during the 2nd quarter worth $29,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.